Journal of Brain Research

ISSN: 2684-4583

Open Access

Understanding the Peritumoural Brain Zone of Glioblastoma: CDK4 and EXT2 Could Be Potential Malignancy-Drivers


Louis Rokka*

Glioblastoma (GBM) is the most aggressive and lethal primary brain tumor in adults. Despite significant advances in medical science, the prognosis for GBM patients remains poor, with a median survival of around 15 months. One of the primary challenges in treating GBM is the invasive nature of the tumor, leading to tumor cells infiltrating surrounding healthy brain tissue beyond the visible tumor mass. This region surrounding the tumor, known as the peritumoural brain zone, plays a crucial role in the progression and recurrence of GBM. Recent research has shown that several genetic factors, including CDK4 and EXT2, could play vital roles in driving malignancy within this zone. This article aims to shed light on the importance of understanding the peritumoural brain zone of GBM and explore the potential implications of CDK4 and EXT2 in the tumor's malignancy.


Share this article

Google Scholar citation report
Citations: 2

Journal of Brain Research received 2 citations as per Google Scholar report

Journal of Brain Research peer review process verified at publons

Indexed In

arrow_upward arrow_upward